Working… Menu

Study of BHV-4157 in Alzheimer's Disease (T2 Protect AD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03605667
Recruitment Status : Active, not recruiting
First Posted : July 30, 2018
Last Update Posted : June 4, 2021
Alzheimer's Disease Cooperative Study (ADCS)
Information provided by (Responsible Party):
Biohaven Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : November 23, 2020
Estimated Study Completion Date : January 23, 2022